Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 486.00
-3.00 (-0.61%)
Apr 17, 2026, 3:30 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 3.57 billion as of April 17, 2026. Its market cap has decreased by -41.37% in one year.
Market Cap
3.57B
Enterprise Value
2.69B
Revenue
72.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
486.00
Market Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 3.57B, a decrease of -29.77%. That is a compound annual growth rate of -6.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.57B | 26.43% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kohjin Bio | 6.96B |
| Soiken Holdings | 6.57B |
| Noile-Immune Biotech | 6.50B |
| TMS Co., Ltd. | 6.46B |
| Linical | 5.74B |
| D. Western Therapeutics Institute | 5.11B |
| Ribomic | 4.67B |
| Transgenic Group | 4.40B |